Patents by Inventor Stephen Y. CHAN

Stephen Y. CHAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11672795
    Abstract: Provided herein are compositions and methods for treating pulmonary vascular disease in a subject comprising administering to the subject a therapeutically effective amount of a YAP/TAZ inhibiting composition and/or a GLS1 inhibiting composition.
    Type: Grant
    Filed: January 14, 2021
    Date of Patent: June 13, 2023
    Assignees: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, THE BRIGHAM AND WOMEN'S HOSPITAL INC.
    Inventors: Stephen Y. Chan, Thomas Bertero
  • Publication number: 20210154187
    Abstract: Provided herein are compositions and methods for treating pulmonary vascular disease in a subject comprising administering to the subject a therapeutically effective amount of a YAP/TAZ inhibiting composition and/or a GLS1 inhibiting composition.
    Type: Application
    Filed: January 14, 2021
    Publication date: May 27, 2021
    Inventors: Stephen Y. CHAN, Thomas BERTERO
  • Patent number: 10925869
    Abstract: Provided herein are compositions and methods for treating pulmonary vascular disease in a subject comprising administering to the subject a therapeutically effective amount of a YAP/TAZ inhibiting composition and/or a GLS1 inhibiting composition.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: February 23, 2021
    Assignees: University of Pittsburgh—Of The Commonwealth System of Higher Education, The Brigham and Women's Hospital, Inc.
    Inventors: Stephen Y. Chan, Thomas Bertero
  • Publication number: 20190298710
    Abstract: Provided herein are compositions and methods for treating pulmonary vascular disease in a subject comprising administering to the subject a therapeutically effective amount of a YAP/TAZ inhibiting composition and/or a GLS1 inhibiting composition.
    Type: Application
    Filed: May 25, 2017
    Publication date: October 3, 2019
    Applicants: University of Pittsburgh-of the Commonwealth System of Higher Education, The Brigham and Women's Hospital, Inc.
    Inventors: Stephen Y. CHAN, Thomas BERTERO
  • Publication number: 20170226507
    Abstract: The present invention relates to methods, kits and compositions to treat hypertension in a subject comprising inhibiting activity or expression of at least one microRNA.
    Type: Application
    Filed: May 5, 2015
    Publication date: August 10, 2017
    Applicant: The Brigham and Women's Hospital, Inc.
    Inventors: Stephen Y. CHAN, Thomas BERTERO